Latest Insider Transactions at Viemed Healthcare, Inc. (VMD)
This section provides a real-time view of insider transactions for Viemed Healthcare, Inc. (VMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of VIEMED HEALTHCARE, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of VIEMED HEALTHCARE, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 18
2023
|
Casey Hoyt Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
42,343
+0.97%
|
-
|
|
Jan 18
2023
|
Casey Hoyt Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,114
-0.66%
|
$98,798
$7.77 P/Share
|
|
Jan 18
2023
|
Michael Moore President |
BUY
Exercise of conversion of derivative security
|
Direct |
28,469
+0.77%
|
-
|
|
Jan 18
2023
|
Michael Moore President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,490
-0.52%
|
$66,430
$7.77 P/Share
|
|
Jan 18
2023
|
William Todd Zehnder Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
28,469
+6.71%
|
-
|
|
Jan 18
2023
|
William Todd Zehnder Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,490
-4.99%
|
$66,430
$7.77 P/Share
|
|
Jan 18
2023
|
Jerome Cambre Vice President of Sales |
BUY
Exercise of conversion of derivative security
|
Direct |
7,808
+5.5%
|
-
|
|
Jan 18
2023
|
Jerome Cambre Vice President of Sales |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,003
-4.56%
|
$21,021
$7.77 P/Share
|
|
Dec 22
2022
|
Timothy Smokoff Director |
SELL
Open market or private sale
|
Direct |
14,000
-17.21%
|
$140,000
$10.09 P/Share
|
|
Dec 22
2022
|
Timothy Smokoff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+14.69%
|
$28,000
$2.27 P/Share
|
|
Dec 21
2022
|
Timothy Smokoff Director |
SELL
Open market or private sale
|
Direct |
11,900
-15.02%
|
$119,000
$10.4 P/Share
|
|
Dec 21
2022
|
Timothy Smokoff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,900
+13.06%
|
$23,800
$2.27 P/Share
|
|
Aug 23
2022
|
Timothy Smokoff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,178
+16.37%
|
-
|
|
Aug 23
2022
|
Nitin Kaushal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,178
+11.39%
|
-
|
|
Aug 23
2022
|
Sabrina Heltz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,178
+47.31%
|
-
|
|
Aug 23
2022
|
Bruce D Greenstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,178
+20.12%
|
-
|
|
Aug 23
2022
|
William Frazier Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,178
+18.11%
|
-
|
|
Aug 23
2022
|
Randy E. Dobbs Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,504
+16.39%
|
-
|
|
May 09
2022
|
Ewell Patrick Eagan General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
101
-100.0%
|
$505
$5.26 P/Share
|
|
May 09
2022
|
Ewell Patrick Eagan General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
101
+50.0%
|
-
|
|
May 09
2022
|
Jerome Cambre Vice President of Sales |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,090
-1.61%
|
$15,450
$5.26 P/Share
|
|
May 09
2022
|
Jerome Cambre Vice President of Sales |
BUY
Exercise of conversion of derivative security
|
Direct |
3,090
+1.59%
|
-
|
|
May 09
2022
|
William Todd Zehnder Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,040
-1.82%
|
$50,200
$5.26 P/Share
|
|
May 09
2022
|
William Todd Zehnder Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,040
+1.79%
|
-
|
|
May 09
2022
|
Trae Fitzgerald Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,582
-2.19%
|
$17,910
$5.26 P/Share
|
|
May 09
2022
|
Trae Fitzgerald Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,582
+2.14%
|
-
|
|
May 09
2022
|
Michael Moore President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,234
-0.19%
|
$51,170
$5.26 P/Share
|
|
May 09
2022
|
Michael Moore President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,234
+0.19%
|
-
|
|
May 09
2022
|
Casey Hoyt Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,140
-0.24%
|
$75,700
$5.26 P/Share
|
|
May 09
2022
|
Casey Hoyt Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,140
+0.24%
|
-
|
|
Nov 04
2021
|
Sabrina Heltz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,942
+50.0%
|
-
|
|
Aug 19
2021
|
Bruce D Greenstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,142
+17.22%
|
-
|
|
Aug 19
2021
|
Nitin Kaushal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,142
+8.35%
|
-
|
|
Aug 19
2021
|
William Frazier Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,142
+14.92%
|
-
|
|
Aug 19
2021
|
Timothy Smokoff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,142
+13.07%
|
-
|
|
Aug 19
2021
|
Randy E. Dobbs Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,579
+13.09%
|
-
|
|
May 11
2021
|
Casey Hoyt Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
10,000
-0.47%
|
-
|
|
May 09
2021
|
Trae Fitzgerald Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
17,046
-8.66%
|
$153,414
$9.57 P/Share
|
|
May 09
2021
|
Trae Fitzgerald Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,046
+7.35%
|
-
|
|
May 09
2021
|
Nitin Kaushal Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,352
-2.81%
|
$21,168
$9.57 P/Share
|
|
May 09
2021
|
Nitin Kaushal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,352
+2.74%
|
-
|
|
May 09
2021
|
William Frazier Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,352
-5.79%
|
$21,168
$9.57 P/Share
|
|
May 09
2021
|
William Frazier Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,352
+5.47%
|
-
|
|
May 09
2021
|
William Todd Zehnder Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
63,264
-9.16%
|
$569,376
$9.57 P/Share
|
|
May 09
2021
|
William Todd Zehnder Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
63,264
+7.62%
|
-
|
|
May 09
2021
|
Jerome Cambre Vice President of Sales |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,682
-7.37%
|
$150,138
$9.57 P/Share
|
|
May 09
2021
|
Jerome Cambre Vice President of Sales |
BUY
Exercise of conversion of derivative security
|
Direct |
16,682
+6.35%
|
-
|
|
May 09
2021
|
Michael Moore President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
65,071
-1.17%
|
$585,639
$9.57 P/Share
|
|
May 09
2021
|
Michael Moore President |
BUY
Exercise of conversion of derivative security
|
Direct |
65,071
+1.14%
|
-
|
|
May 09
2021
|
Casey Hoyt Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
70,006
-1.06%
|
$630,054
$9.57 P/Share
|